2017
DOI: 10.1016/j.clml.2017.07.131
|View full text |Cite
|
Sign up to set email alerts
|

Single Institution Experience with Nivolumab in Treatment of Patients with Relapsed or Refractory Hodgkin’s Lymphoma

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles